Skip to content

Use of anti-stenosis catheters for the prevention and treatment of benign postoperative esophageal strictures

Use of anti-stenosis catheters for the prevention and treatment of benign postoperative esophageal strictures

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112721
Enrollment
Unknown
Registered
2025-11-19
Start date
2025-11-12
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal stricture

Interventions

Anti-stricture catheter group:Anti-stricture catheter

Sponsors

Jiangyin People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients voluntarily enrolled in this study, signed informed consent forms, and demonstrated good compliance; 2. Open to both genders, aged 18–80 years; 3. Meet the indications for oesophageal ESD (Chinese Society of Oncology, Early Diagnosis and Treatment Working Group. Chinese Expert Consensus on Early Diagnosis and Treatment of Oesophageal Cancer. Chinese Journal of Cancer, 2022, 44(10):1066-1075); 4. Oesophageal lesion extent covers no less than half the circumference; 5. Patients planning long-term follow-up at this hospital.

Exclusion criteria

Exclusion criteria: 1. Patients with malignant oesophageal strictures; 2. Patients with cardiopulmonary insufficiency unable to tolerate general anaesthesia; 3. Patients with haemostatic abnormalities; 4. Patients unable to sign an informed consent form.

Design outcomes

Primary

MeasureTime frame
Esophageal stricture rate at the 30-day postoperative mark;Esophageal stricture rate at the 90-day postoperative mark;Number of postoperative endoscopic balloon/bougie dilations;

Secondary

MeasureTime frame
Incidence of treatment-related adverse events;

Countries

China

Contacts

Public ContactFangjun Wang

Jiangyin People's Hospital

timeswang@163.com+86 138 0616 3967

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026